At the time that “Hard indicators” are high again with 106 deaths for the second consecutive day, on Thursday, 17,662 new infections and 568 intubated patients, a ray of optimism are the new “weapons” in the quiver of scientists for the “battle” against the pandemic.
The Novavax protein vaccine is expected on February 21 in Greece and it is estimated that 474,000 installments will have been delivered in March. Also in April it arrives in our country Sanofi vaccinewhile the drugs related to the prophylactic treatment started to be administered from last Wednesday, as the Deputy Minister of Health Mina Gaga stated on Thursday, in the established information.
He also referred to the value of the Novavax vaccine “for those who are afraid of the mRNA vaccine and want a protein vaccine”.
Of course, this preparation “has not yet entered the algorithm of the Greek vaccination coverage”, so we do not know at this time, whether someone who has done 2 doses with mRNA vaccine can make a booster dose with Novavax, so everything will be discussed at the right time, according to Ms. Papaevangelou.
As for medicines, 300 applications have already been approved and several of them have been delivered or are being delivered, he stressed. At the beginning of March, antiviral pills from another company will be delivered to our country, as well as other drugs that offer prophylaxis for the coronavirus, he added.
As if said. Minister of Health, the medicines are approved in 24 hours and in 48 hours at the latest, they are delivered to those who need them, that is, those who are at the beginning of the infection, in their home.
In the meantime, according to the prognostic models of Sotiris Tsiodras, as Mrs. Papaevangelou underlined, at the end of February the number of intubated patients will be around 500. In addition, in the coming weeks, yes, the “hard indicators” are expected to fall, but the The spread is still very high and therefore any relaxation, once decided, will initially concern the vaccinated.
Regarding the administration of Pfizer and Merck pills, the Deputy Minister noted that more than 300 applications have been approved so far and have already started to be delivered home to patients who meet the criteria. Although the treatment has not yet been approved by Coreper, it is used exceptionally in Greece under the responsibility of patients.
According to the results of clinical trials, the pill reduces by 30% the risk of hospitalization and death in patients at risk of severe deterioration.
See all the news
Follow Skai.gr on Google News
and be the first to know all the news
Skai
